Report : Antibody Testing Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Kits, Chemical and Reagents, Consumables); Indication (Pregnancy, Cardiovascular Diseases, Autoimmune Diseases, Infectious Diseases, Oncology, Endocrine Diseases, Others); End-User (Hospitals, Academic and Research Institutes, Diagnostic Laboratories, Biopharmaceutical Companies), and Geography.
Antibody Testing Market for Porcine Segment to Grow At Highest CAGR during 2020–2027
According to our new market research study on “Antibody Testing Market to 2027 – Global Analysis and Forecast – by vaccine type and route of administration,” the market is expected to reach US$ 10,740.69 million by 2027 from US$ 6,415.90 million in 2019. The market is estimated to grow with a CAGR of 6.7% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.
Based on Antibody Testing products, the market is segmented into Kits, Chemical and Reagents, Consumables. In 2019, the kits segment accounted for the highest share of the market. Growth of this segment is attributed to the large number of manufacturers like Abbott, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., and others and higher adoption of kits in various research processes. The same segment is likely to register highest CAGR in the global Antibody Testing market during the forecast period.
Global Antibody Testing Market, based on indication, the Antibody Testing market is segmented into Pregnancy, Cardiovascular Diseases, Autoimmune Diseases, Infectious Diseases, Oncology, Endocrine Diseases, Others. The Infectious Diseases segment held the largest share of the market in 2019, and same segment is anticipated to register the highest CAGR of 8.0% in the market during the forecast period.
Global Antibody Testing Market, based on end user, the Antibody Testing market is segmented into Hospitals, Academic and Research Institutes, Diagnostic Laboratories, Biopharmaceutical Companies. The Diagnostic Laboratories segment held the largest share of the market in 2019, and same segment is anticipated to register the highest CAGR of 7.4 % in the market during the forecast period.
COVID-19 pandemic has become the most significant challenge across the world. This challenge will be frightening especially in developing countries across the globe as it will lead to reducing imports due to disruptions in global trade. Till date no definitive treatment against COVID 19 has been established. Hence, lack of definitive therapy offers significant opportunities for antibody testing market as US FDA has recently approved use of plasma therapy for critically ill COVID 19 patients. In long run Antibody Testing market will have significant growth prospects as many market players has received emergency use authorization for their newly developed antibody tests. All such developments will add up to the future demand for antibody testing market.
Thermo Fisher Scientific, Abbott Laboratories, Bio-Rad Laboratories, Inc., Beckton, Dickinson And Company, F. Hoffmann La Roche, Agilent Technologies, DiaSorin, Zeus Scientific, ABCAM, Trinity Biotech are among the leading companies operating in the Antibody Testing market.
The Report Segments Global Antibody Testing Market as Follows:
By End User